The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, H.
Right arrow Articles by Masuda, E. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, H.
Right arrow Articles by Masuda, E. S.
The Journal of Immunology, 2005, 174: 5288-5297.
Copyright © 2005 by The American Association of Immunologists

A Novel E3 Ubiquitin Ligase TRAC-1 Positively Regulates T Cell Activation

Haoran Zhao1, Connie C. Li2, Jorge Pardo3, Peter C. Chu, Charlene X. Liao4, Jianing Huang, John G. Dong, Xiulan Zhou, Qi Huang, Betty Huang, Mark K. Bennett5, Susan M. Molineaux5, Henry Lu, Sarkiz Daniel-Issakani, Donald G. Payan and Esteban S. Masuda

Rigel Pharmaceuticals, Inc., South San Francisco, CA 94080

TRAC-1 (T cell RING (really interesting new gene) protein identified in activation screen) is a novel E3 ubiquitin ligase identified from a retroviral vector-based T cell surface activation marker screen. The C-terminal truncated TRAC-1 specifically inhibited anti-TCR-mediated CD69 up-regulation in Jurkat cells, a human T leukemic cell line. In this study, we show that TRAC-1 is a RING finger ubiquitin E3 ligase with highest expression in lymphoid tissues. Point mutations that disrupt the Zn2+-chelating ability of its amino-terminal RING finger domain abolished TRAC-1’s ligase activity and the dominant inhibitory effect of C-terminal truncated TRAC-1 on TCR stimulation. The results of in vitro biochemical studies indicate that TRAC-1 can stimulate the formation of both K48- and K63-linked polyubiquitin chains and therefore could potentially activate both degradative and regulatory ubiquitin-dependent pathways. Antisense oligonucleotides to TRAC-1 specifically reduced TRAC-1 mRNA levels in Jurkat and primary T cells and inhibited their activation in response to TCR cross-linking. Collectively, these results indicate that the E3 ubiquitin ligase TRAC-1 functions as a positive regulator of T cell activation.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
K.-i. Arimoto, H. Takahashi, T. Hishiki, H. Konishi, T. Fujita, and K. Shimotohno
Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125
PNAS, May 1, 2007; 104(18): 7500 - 7505.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Fortier and J. Kornbluth
NK Lytic-Associated Molecule, Involved in NK Cytotoxic Function, Is an E3 Ligase.
J. Immunol., June 1, 2006; 176(11): 6454 - 6463.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. A. Wohlfert, L. Gorelik, R. Mittler, R. A. Flavell, and R. B. Clark
Cutting Edge: Deficiency in the E3 Ubiquitin Ligase Cbl-b Results in a Multifunctional Defect in T Cell TGF-beta Sensitivity In Vitro and In Vivo
J. Immunol., February 1, 2006; 176(3): 1316 - 1320.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.